US pressing India to avoid capping medical device prices, allow withdrawals Ruby Khatun Khatun6 Oct 2017 10:33 AM ISTNew Delhi: The United States is pressing India not to extend price caps on medical devices and wants the government to allow firms to withdraw...
NPPA says Abbott can discontinue Xience Alpine stent in a year, check out details Ruby Khatun Khatun27 Sept 2017 12:42 PM ISTNew Delhi: Through a recent notice, Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National...
NPPA allows Abbott to withdraw bioresorbable stent from India Ruby Khatun Khatun22 Sept 2017 5:00 PM ISTNew Delhi: Through a recent notice, Government of India , Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National...
Abbott pulls back its bioresorbable stent-ABSORB, also moves to withdraw XIENCE from India Ruby Khatun Khatun11 Sept 2017 3:17 PM ISTNew Delhi: Abbott has taken up the decision to stop the sales of sales of its bioresorbable coronary stent 'Absorb' globally due to low commercial...
Abbott India Q1 net profit down 35 percent at Rs 48 crore Ruby Khatun Khatun10 Aug 2017 9:16 AM ISTNew Delhi: Pharmaceuticals firm Abbott India on Tuesday reported 34.8 per cent decline in net profit to Rs 48.25 crore for the first quarter ended...
4 more medical devices to be added to price control list, document shows Ruby Khatun Khatun7 Jun 2017 1:36 PM ISTNew Delhi/Mumbai: India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for...
Govt rejects Abbott, Medtronic applications to withdraw stents Ruby Khatun Khatun27 April 2017 3:29 PM ISTNew Delhi: The government on Wednesday rejected applications by multinational firms Abbott Healthcare Pvt Ltd and India Medtronic Pvt Ltd to withdraw...
Government Prohibits Stent companies to withdraw stents for Next Six Months Ruby Khatun Khatun25 April 2017 3:12 PM ISTNew Delhi: In a bid to prevent Multinational Stent makers from removing their next generation stents from the Indian Market, the central government...
After Abbott, two more Stent makers seek withdrawal of New Gen Stents Ruby Khatun Khatun24 April 2017 1:39 PM ISTMUMBAI: Soon after Abbott was seen seeking withdrawal of its withdraw two types of stents from the Indian market, reports are coming in that two more...
Abbott decides to withdraw 2 stent types from India supriya kashyap kashyap22 April 2017 9:47 AM ISTNew Delhi : Healthcare major Abbott has decided to withdraw two types of stents from the Indian market in the wake of drug price regulator National...
Novartis, Abbott, Emcure face allegations of cartelisation in anti-diabetes drug Vildagliptin savita thakur thakur26 March 2017 11:33 AM ISTThe Swiss drug maker Novartis and US based Abbott along with domestic companies Emcure and USV Pharma are under the lens of Health Ministry and...
Abbott sales rep commits suicide, blames company in suicide note Geeta Sharma Sharma25 July 2016 5:47 PM IST Mumbai:The suicide of Ashish Awasthi, the 35 year old sales representative found dead on a railway track in Indore has sparked both controversy...
